National Advisory Committee on Immunization says vaccine can go to younger people, under certain conditions
Apr 19, 2021
Many provinces have been lowering the age of eligibility for the AstraZeneca-Oxford vaccine to as young as 40.
Health Canada approved the AstraZeneca-Oxford vaccine for use in Canada for people 18 and over under an interim order on Feb. 26, 2021.
But a month later, on March 29, Canada’s National Advisory Committee on Immunization recommended that provinces pause the use of the vaccine in those under the age of 55 due to safety concerns. That was after reports of rare cases of blood clots in some patients in Europe, mostly younger women.
Now CBC News has obtained documents that show NACI will recommend expanding the use of AstraZeneca-Oxford to younger age groups under specific conditions when it releases its new guidelines.
Read more: https://www.cbc.ca/news/health/astrazeneca-vaccine-roundup-1.5993374